CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
control groupother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07088887
NCT07088887N/ACompleted

Bruxism Awareness as a Pre-Treatment Consideration in Dental Implantology

Saglik Bilimleri Universitesi·observational·Posted Jul 28, 2025·Updated Jul 28, 2025

In Brief

An observational study evaluating control group for Bruxism. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Bruxism is a parafunctional habit characterized by clenching or grinding of the teeth and/or mandibular thrusting, which may occur during sleep or wakefulness. It is associated with various dental complications, including implant failures. Despite its prevalence, awareness of bruxism among patients remains limited, and diagnostic methods vary. This study aims to evaluate the presence and type of bruxism in patients undergoing dental implant treatment and to assess their awareness levels. The findings may help prevent implant-related complications by supporting early identification and appropriate management of bruxism. Research Questions What is the prevalence of awake and sleep bruxism in patients scheduled for dental implant treatment? To what extent are patients aware of their bruxism habits prior to treatment? What are the most common signs and symptoms of bruxism observed in this patient group? Is there a correlation between patients' self-reported bruxism and clinical findings? Can increased bruxism awareness before implant procedures help reduce the risk of future implant and prosthetic complications?

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBruxism
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedJul 28, 2025
Enrollment StartMar 1, 2025
Primary CompletionJun 15, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11 months ago

Interventions

control groupother

The control group included patients aged 18-65 who were systemically healthy, had no clinical or self-reported signs of bruxism, and were eligible for implant treatment. Data collected included demographic characteristics (age, gender), systemic and periodontal health status, and clinical examination findings confirming the absence of bruxism. These patients also completed the Fonseca Anamnestic Index (FAI) to assess temporomandibular disorder (TMD) symptoms and the Perceived Stress Scale-14 (PSS-14) to evaluate emotional stress levels. A bruxism awareness questionnaire was also applied to determine baseline knowledge in individuals without bruxism. All assessments were conducted before implant surgery using standardized diagnostic tools.